This symposium will showcase how the work of CAT has contributed to the regulatory framework for ATMPs in Europe and to the approval of these innovative products. It will also outline the evolution of CAT and its adaptation to the challenges posed by novel classes of ATMPs. The ultimate objective is to ensure that high quality, safe and efficacious […]
This meeting is about translating innovation into acces for ATMPs: third EU-innovation network multi-stakeholder meeting. The recorded meeting can be found here.
A workshop organized for and by ATMP operators, technicians and other experts handling, developing and/or producing ATMPs. The goal of the workshop was to exchange experiences, common practices and challenges, stimulate interaction and foster collaborations. Program: 09.00 - 09.30 Welcome with coffee & tea Session 1: Disinfection 09.30 - 10.15 Karin Hanraets (STAXS): Training […]
Finding clinical trials involving ATMPs are still a challenge in the current clinical trial registries. This symposium is a great opportunity to gain insights and discuss bottlenecks with experts in clinical trial registries. Find detailed information on the program and the overview of the day below. Participation is free but you will have to register […]
About Join us for an interactive workshop on the practical application of Quality by Design (QbD) and the critical challenges of process comparability and tech transfer of ATMPs. Since regulations for ATMPs provide a framework rather than a strict checklist, developers must learn to navigate these guidelines. Expert consultants will kick off by aligning the […]
The primary aim of CINNAMON https://www.cost.eu/actions/CA24115/ is to establish a collaborative network of European centres to standardise, expand, and optimise expertise in CAR-T cell therapies. This includes promoting equitable access to these therapies, fostering innovation in ATMPs, and delivering comprehensive training programmes for scientists, innovators, and clinicians—particularly, though not exclusively, in Inclusiveness Target Countries (ITCs). By […]
The Medicines Evaluation Board (MEB) and the Central Committee on Research Involving Human Subjects (CCMO) organize Science Day 2026. This year’s focus is on N-of-1 individualized therapies and how these highly tailored treatments can be responsibly brought to patients. Click here to view the program and register for the event